The Consensus Definition of Bronchopulmonary Dysplasia Is an Adequate Predictor of Lung Function at Preschool Age.
bronchopulmonary dysplasia
lung function
preschool age
preterm infant
spirometry
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
06
12
2021
accepted:
03
01
2022
entrez:
21
2
2022
pubmed:
22
2
2022
medline:
22
2
2022
Statut:
epublish
Résumé
Recent attempts to refine the definition bronchopulmonary dysplasia (BPD) have based its predictive capacity on respiratory outcome in the first 2 years of life, eliminating the pre-existing requirement of 28 days of oxygen therapy prior to 36 weeks postmenstrual age (PMA). The objective of this study was to assess the utility of the 2001 consensus definition in predicting impaired lung function at preschool age. This cohort study included children aged 4-6 years old who were born at gestational age (GA) <32 weeks or bodyweight <1500 g. Univariate and multivariate analyses were performed to assess differences in antenatal and neonatal variables between BPD and non-BPD children. All participants underwent incentive spirometry. Lung function parameters were contrasted with the Global Lung Function Initiative (GLI-2012) reference equations and, together with antenatal and neonatal variables, compared among the different subgroups (no BPD, mild BPD, and moderate-to-severe BPD). A multivariate model was generated to identify independent risk factors for impaired lung function. GA, hemodynamically significant patent ductus arteriosus, and late sepsis were independent risk factors for the development of BPD. A total of 119 children underwent incentive spirometry. All lung function parameters were significantly altered relative to reference values. Greater impairment of lung function was observed in the mild BPD vs. the no BPD group (forced expiratory volume in the first 0.75 seconds [FEV The 2001 consensus definition of BPD has adequate predictive capacity for lung function measured by spirometry at 4-6 years of age. Moderate-to-severe BPD was the best predictor of respiratory impairment. Children with mild BPD showed greater alteration of FEV
Sections du résumé
BACKGROUND
BACKGROUND
Recent attempts to refine the definition bronchopulmonary dysplasia (BPD) have based its predictive capacity on respiratory outcome in the first 2 years of life, eliminating the pre-existing requirement of 28 days of oxygen therapy prior to 36 weeks postmenstrual age (PMA). The objective of this study was to assess the utility of the 2001 consensus definition in predicting impaired lung function at preschool age.
METHODS
METHODS
This cohort study included children aged 4-6 years old who were born at gestational age (GA) <32 weeks or bodyweight <1500 g. Univariate and multivariate analyses were performed to assess differences in antenatal and neonatal variables between BPD and non-BPD children. All participants underwent incentive spirometry. Lung function parameters were contrasted with the Global Lung Function Initiative (GLI-2012) reference equations and, together with antenatal and neonatal variables, compared among the different subgroups (no BPD, mild BPD, and moderate-to-severe BPD). A multivariate model was generated to identify independent risk factors for impaired lung function.
RESULTS
RESULTS
GA, hemodynamically significant patent ductus arteriosus, and late sepsis were independent risk factors for the development of BPD. A total of 119 children underwent incentive spirometry. All lung function parameters were significantly altered relative to reference values. Greater impairment of lung function was observed in the mild BPD vs. the no BPD group (forced expiratory volume in the first 0.75 seconds [FEV
CONCLUSION
CONCLUSIONS
The 2001 consensus definition of BPD has adequate predictive capacity for lung function measured by spirometry at 4-6 years of age. Moderate-to-severe BPD was the best predictor of respiratory impairment. Children with mild BPD showed greater alteration of FEV
Identifiants
pubmed: 35186811
doi: 10.3389/fped.2022.830035
pmc: PMC8854776
doi:
Types de publication
Journal Article
Langues
eng
Pagination
830035Informations de copyright
Copyright © 2022 Rite, Martín de Vicente, García-Iñiguez, Couce, Samper, Montaner and Ruiz de la Cuesta.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Pediatrics. 1988 Oct;82(4):527-32
pubmed: 3174313
Arch Bronconeumol (Engl Ed). 2018 Jan;54(1):24-30
pubmed: 28935165
Neonatology. 2019;115(4):384-391
pubmed: 30974430
Respir Med. 2013 Dec;107(12):1966-76
pubmed: 23880413
Pediatrics. 2005 Dec;116(6):1353-60
pubmed: 16322158
J Pediatr. 2018 Jun;197:8-10
pubmed: 29605396
Am J Respir Crit Care Med. 2010 Jul 15;182(2):237-45
pubmed: 20378729
Pediatr Pulmonol. 2013 May;48(5):449-55
pubmed: 22826206
JAMA. 2015 Sep 8;314(10):1039-51
pubmed: 26348753
N Engl J Med. 1967 Feb 16;276(7):357-68
pubmed: 5334613
Indian J Pediatr. 2014 Mar;81(3):275-8
pubmed: 23868538
Eur J Pediatr. 2019 Dec;178(12):1859-1866
pubmed: 31486896
Thorax. 2018 Dec;73(12):1174-1176
pubmed: 29605813
Front Pediatr. 2020 Sep 22;8:577673
pubmed: 33072679
Am J Obstet Gynecol. 2005 Apr;192(4):1162-6
pubmed: 15846196
Allergol Immunopathol (Madr). 2018 Jan - Feb;46(1):87-98
pubmed: 28668285
Chest. 2011 Jan;139(1):52-9
pubmed: 20522571
Lancet. 1993 Jul 24;342(8865):193-8
pubmed: 8100927
Am J Perinatol. 2018 May;35(6):537-540
pubmed: 29694991
Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9
pubmed: 11401896
J Pediatr. 2018 Jun;197:300-308
pubmed: 29551318
J Pediatr. 1979 Nov;95(5 Pt 2):851-8
pubmed: 385819
Paediatr Respir Rev. 2006;7 Suppl 1:S30-2
pubmed: 16798588
Am J Respir Crit Care Med. 2019 Sep 15;200(6):751-759
pubmed: 30995069
J Allergy Clin Immunol. 2021 May;147(5):1949-1958
pubmed: 33453287
Acta Paediatr. 2004 Mar;93(3):316-21
pubmed: 15124832
Lancet Respir Med. 2019 Aug;7(8):677-686
pubmed: 31078498
J Pediatr. 1979 Nov;95(5 Pt 2):819-23
pubmed: 385815
Lancet Child Adolesc Health. 2018 May;2(5):350-359
pubmed: 30169268
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Am J Respir Crit Care Med. 2007 Jun 15;175(12):1304-45
pubmed: 17545458
Am J Respir Crit Care Med. 2009 Sep 15;180(6):547-52
pubmed: 19574442
Nat Rev Dis Primers. 2019 Nov 14;5(1):78
pubmed: 31727986
An Pediatr (Barc). 2008 Jun;68(6):544-51
pubmed: 18559193